Febbo Phillip G.'s Form 4 filing
Illumina, Inc. (ILMN) · filed Apr 7, 2022
- Accession no.
- 0001127602-22-011725
- Filed
- Apr 7, 2022
- Trade date
- Apr 5-6, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $715.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Febbo Phillip G.CIK 0001649245 | Officer (SVP Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2022 | Common Stock | FTax withholdingDisposed | −131 | $363.84 | −$47,663.04 | 7,762 | Direct | |
| Apr 6, 2022 | Common Stock | SSaleDisposed | −1,988 | $360.01 | −$715,699.88 | 5,774 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.